The mutant protein Ataxin-1, involved in SCA1 pathogenesis, is a transcription activator, whilst the polyglutamine expansion of SCA 17 occurs within the TATA box-binding protein (TBP), an essential transcription factor [64, 65]. The gene discussed is TBP; the disease is spinocerebellar ataxia type 17.